Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Shaving cut with Occam’s Razor
April 4, 2012
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
I arrived at this year’s Society of Toxicology annual meeting in San Francisco primed to bring back a great multimedia recap, with plenty of photos and video from the exhibit hall, and lots of perspective from attendees and exhibitors about the shape of the business. But a funny thing happened on the way to the Moscone Center: I discovered that it’s very difficult to get people to talk on the record at that event. I was perplexed the first day when, after extended wrangling with marketing and PR staff, I was repeatedly rebuffed in my attempts to shoot “from the booth” video interviews. Similarly, most of my requests for short interviews about the event fell on deaf ears. It was only the second year I’d attended SoT, but after more than 15 years of covering trade shows, I’d never seen this level of press-shyness. The second morning of the event, I arrived a bit early and heard the pre-show PA announcement. The speaker mentioned, “Two people were seen taking photos from the exhibit hall floor, and security has been alerted. Also, if you’re approached by someone saying they’re shooting a documentary for SoT, please be advised that they are not legitimate, and report them to security.” That’s when it hit me; if I applied Occam’s Razor, like in That Simpsons Episode, I’d come to a logical conclusion: The RAND Corporation, in conjunction with the saucer people, under the supervision of the reverse vampires, are forcing exhibitors to go without publicity in a fiendish plot to eliminate business magazines! But then one of my cancellations stopped by my booth and told me that there were concerns about being targeted by animal rights protestors, since companies at SoT are in-volved in some way with animal testing models. I decided that this was a plausible explanation, albeit a less exciting one. Still, it allowed me to get more background conversations in, and to build up a better grasp of the tumult working its way through the preclinical CRO industry. Which I’ll need, since our Preclinical Outsourcing columnist, Steve Snyder, is departing this issue, after seven years of writing for us. You can find his farewell column here, but I’m hoping he’ll come back for an occasional feature; as I learned during SoT, there’s a lot going on in the preclinical space, and we need to make sense of what it means for the rest of the outsourcing industry. That said, I’m not convinced there isn’t a conspiracy afoot. Given the concern about protestors and subversives and the sensitive business of SOT’s constituents, isn’t it a bit suspicious that this year’s conference was located in San Francisco of all places? I still remember the commando-style level of protesting that took place when BIO was held in San Francisco back in 2004. (Now that I think about it, it seems like that was a more protest-y time overall in America, today’s Occupy Wall Street offshoots notwithstanding.) –Gil P.S.: We’ll have some video up from SoT soon. And if you’re looking for Society-approved photos from their annual event, you can find them here. In Memoriam Jeffrey McGinnis, of McGinnisPR, died in March. He was a good friend of the magazine, and one of the most pleasant people I’ve had the opportunity to meet in Contract Pharma’s 12-year history. We’ll miss him dearly.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !